4//SEC Filing
Sorrento Therapeutics, Inc. 4
Accession 0001209191-15-037682
CIK 0000850261operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 11:43 AM ET
Size
5.6 KB
Accession
0001209191-15-037682
Insider Transaction Report
Form 4
Durand Mark
Director
Transactions
- Award
Stock Options
2015-04-29+120,000→ 145,000 totalExercise: $8.95Exp: 2025-04-29→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]30,000 of the original number of shares subject to this option shall vest and become exercisable on April 29, 2016 and 1/36 of the remaining options shall vest following each one month period of service thereafter, subject to the reporting person's continued service to the Company through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850261
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 11:43 AM ET
- Size
- 5.6 KB